Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Clinical trial NCT03784443 · WITHDRAWN

Trial details

NCT number: NCT03784443
Sponsor: Imperial College London
Status: WITHDRAWN
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Edema Diabetes

Start date: 2019-09-01
Primary completion: 2022-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.